Back to search

National and Kapodistrian University of Athens

Μια προοπτική τυχαιοποιημένη κλινική μελέτη για την εκτίμηση της χρήσης της προκαλσιτονίνης στον καθορισμό της διάρκειας της αντιμικροβιακής αγωγής με παράλληλη ωφέλεια τη μείωση των χρόνιων λοιμωδών επιπλοκών: μελέτη PROGRESS

Abstract

dc:description

Rationale: Although early antimicrobial discontinuation guided by procalcitonin (PCT) has showed decreased antibiotic consumption in lower respiratory tract infections (LRTIs), the outcomes in long-term sepsis sequelae remain unclear. Objective To investigate if PCT-guidance may reduce the incidence of long-term infection-associated adverse events in sepsis. Methods: In this multicenter trial, 266 sepsis (by Sepsis-3 definitions) patients with LRTIs, acute pyelonephritis, or primary bloodstream infection were randomized (1:1) to receive either PCT-guided discontinuation of antimicrobials or standard-of-care (SOC). The discontinuation criterion was ≥80% reduction in PCT levels or any PCT ≤0.5 μg/l at day 5 or later. The primary outcome was the rate of infection-associated adverse events at day 180, a composite of the incidence of any new infection by Clostridioides difficile or multidrug-resistant organisms (MDRO), or any death attributed to baseline C. difficile or MDRO infection. Secondary outcomes included 28-day mortality, length of antibiotic therapy (LOT), and cost of hospitalization. Measurements and Main Results: The rate of infection-associated adverse events was 7.2% (95% CI, 3.8-13.1%; 9/125) versus 15.3% (95% CI, 10.1-22.4%; 20/131) (hazard ratio [HR], 0.45; 95% CI, 0.20-0.98; P=0.045); 28-day mortality 15.2% (95% CI,10-22.5%; 19/125) versus 28.2% (95% CI, 21.2-36.5%; 37/131) (HR, 0.51; 95% CI, 0.29-0.89; P =0.02); and median LOT 5 (range 5 to 7) versus 10 (range 7 to 15) days (P <0.001) in the PCT and SOC arms, respectively. The cost of hospitalization was also reduced in the PCT arm. Conclusions: In sepsis, PCT-guidance was effective in reducing infection-associated adverse events, 28-day mortality, and cost of hospitalization.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kyriazopoulou, Evdoxia
  • Κυριαζοπούλου, Ευδοξία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48157

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kyriazopoulou, Evdoxia; Κυριαζοπούλου, Ευδοξία. Μια προοπτική τυχαιοποιημένη κλινική μελέτη για την εκτίμηση της χρήσης της προκαλσιτονίνης στον καθορισμό της διάρκειας της αντιμικροβιακής αγωγής με παράλληλη ωφέλεια τη μείωση των χρόνιων λοιμωδών επιπλοκών: μελέτη PROGRESS. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/48157